Stock ScreenerStock IdeasLow P/E RatioLow P/E Ratio StocksCompanies with P/E ratios below their industry and market average, with a minimum market cap of $250M+
Stock ScreenerStock IdeasLow P/E Ratio
Market Cap: >= $250M
P/E vs Industry: Pass
P/E vs Market: Pass
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LMAT | LEMAITRE VASCULAR INC | $1.92B | $84.44 | $97.75 | 15.76% | Buy | 4 | 7.82% | 5.28% | 17.10% | 10.83% | |||
| STVN | STEVANATO GROUP SPA | $6.41B | $21.16 | $26.00 | 22.87% | Hold | 1 | 2.24% | 11.28% | 18.00% | 10.71% | |||
| LEU | CENTRUS ENERGY CORP | $4.39B | $241.31 | $248.29 | 2.89% | Buy | 7 | 6.07% | -14.97% | 39.46% | 6.38% | |||
| ENTG | ENTEGRIS INC | $10.43B | $68.80 | $93.80 | 36.34% | Buy | 5 | 4.99% | 29.03% | 18.20% | 8.43% | |||
| HSTM | HEALTHSTREAM INC | $727.17M | $24.51 | $28.00 | 14.24% | Hold | 1 | 5.48% | 7.96% | N/A | N/A | |||
| IAS | INTEGRAL AD SCIENCE HOLDING CORP | $1.72B | $10.22 | $10.40 | 1.76% | Hold | 4 | 8.36% | 22.34% | N/A | N/A | |||
| ARGX | ARGENX SE | $56.06B | $918.50 | $960.08 | 4.53% | Strong Buy | 13 | 1,432.04% | 11.94% | 43.65% | 37.08% | |||
| RACE | FERRARI NV | $92.87B | $383.15 | $490.25 | 27.95% | Strong Buy | 4 | 1.07% | 2.36% | 64.39% | 25.63% | |||
| FIX | COMFORT SYSTEMS USA INC | $30.90B | $876.19 | $955.67 | 9.07% | Strong Buy | 3 | 9.37% | 12.03% | 53.42% | 20.65% | |||
| CBRE | CBRE GROUP INC | $45.11B | $151.58 | $176.50 | 16.44% | Buy | 6 | 7.90% | 28.50% | 35.80% | 10.70% | |||
| ECL | ECOLAB INC | $74.13B | $261.74 | $297.00 | 13.47% | Buy | 10 | 4.14% | 11.45% | 31.20% | 12.69% | |||
| WST | WEST PHARMACEUTICAL SERVICES INC | $18.54B | $257.77 | $346.83 | 34.55% | Strong Buy | 6 | 5.11% | 8.45% | 23.39% | 17.38% | |||
| PGNY | PROGYNY INC | $2.14B | $24.83 | $27.14 | 9.32% | Buy | 7 | 6.99% | 27.07% | 37.77% | 26.59% | |||
| STOK | STOKE THERAPEUTICS INC | $1.60B | $27.93 | $30.43 | 8.95% | Strong Buy | 7 | -62.19% | N/A | -31.77% | -27.17% | |||
| DLR | DIGITAL REALTY TRUST INC | $54.13B | $157.59 | $195.18 | 23.85% | Buy | 11 | 8.27% | -22.97% | 10.44% | 4.93% | |||
| XOMA | XOMA ROYALTY CORP | $394.15M | $31.83 | $104.00 | 226.74% | Buy | 1 | 15.09% | -4.33% | 17.10% | 5.71% | |||
| UI | UBIQUITI INC | $31.18B | $515.44 | $587.50 | 13.98% | Sell | 2 | 3.51% | -1.20% | 92.44% | 51.39% | |||
| CEG | CONSTELLATION ENERGY CORP | $107.98B | $345.78 | $403.75 | 16.76% | Buy | 12 | 4.09% | 12.20% | 35.22% | 9.03% | |||
| ASML | ASML HOLDING NV | $384.86B | $981.04 | $1.16k | 17.73% | Strong Buy | 3 | 4.26% | 8.53% | 75.62% | 29.10% | |||
| WMT | WALMART INC | $853.97B | $107.11 | $117.82 | 10.00% | Strong Buy | 17 | 3.96% | 7.36% | 29.29% | 9.75% | |||
| OLN | OLIN CORP | $2.11B | $18.46 | $24.33 | 31.81% | Buy | 9 | 1.42% | 36.91% | 9.44% | 2.44% | |||
| RMBS | RAMBUS INC | $9.40B | $87.28 | $106.83 | 22.40% | Strong Buy | 6 | 12.60% | 18.34% | 38.18% | 34.98% | |||
| AGX | ARGAN INC | $4.88B | $353.30 | $291.00 | -17.63% | Strong Buy | 4 | 15.30% | 9.38% | 42.19% | 18.79% | |||
| MMSI | MERIT MEDICAL SYSTEMS INC | $5.03B | $84.88 | $102.17 | 20.37% | Strong Buy | 6 | 5.51% | 30.30% | 19.77% | 11.49% | |||
| GLUE | MONTE ROSA THERAPEUTICS INC | $880.39M | $13.52 | $13.00 | -3.85% | Hold | 1 | -28.51% | N/A | -37.39% | -19.99% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.